The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it's not clear the biomarker is valid across all cancer types.

by Anna Azvolinsky

Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker.

by Rob Weker

Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.

by Marcus A. Banks

To gain control over fear of my breast cancer recurring, I called on lessons learned as a 5-year-old confronting the neighborhood bully.

by Joan Harris

Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.

by Kendall K. Morgan

Survivor Profile

Medha Deoras-Sutliff's experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.

by Lindsey Konkel

Medicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.

by Kate Yandell

Q&A

Medical histories capture a vital snapshot of a patient's health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative.

by Marci A. Landsmann

Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.

by Sharon Tregaskis

Forward Look

A therapeutic vaccine targeting advanced cervical cancer.

by Anna Azvolinsky